PACS Group, Inc. (NYSE:PACS – Get Free Report) CEO Jason Murray sold 13,696 shares of the business’s stock in a transaction dated Thursday, October 22nd. The shares were sold at an average price of $47.55, for a total value of $651,244.80. Following the completion of the transaction, the chief executive officer owned 54,257,117 shares in the company, valued at $2,579,925,913.35. This trade represents a 0.03% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.
Jason Hulse Murray also recently made the following trade(s):
- On Friday, October 23rd, Jason Murray sold 68,917 shares of PACS Group stock. The stock was sold at an average price of $48.60, for a total value of $3,349,366.20.
- On Wednesday, October 21st, Jason Murray sold 6,610 shares of PACS Group stock. The stock was sold at an average price of $47.62, for a total value of $314,768.20.
- On Tuesday, October 20th, Jason Murray sold 37,477 shares of PACS Group stock. The stock was sold at an average price of $47.65, for a total value of $1,785,779.05.
- On Monday, October 19th, Jason Murray sold 1,620 shares of PACS Group stock. The shares were sold at an average price of $47.57, for a total value of $77,063.40.
- On Friday, October 16th, Jason Murray sold 8,462 shares of PACS Group stock. The shares were sold at an average price of $47.61, for a total value of $402,875.82.
- On Thursday, October 15th, Jason Murray sold 110,035 shares of PACS Group stock. The shares were sold at an average price of $47.27, for a total value of $5,201,354.45.
- On Wednesday, October 14th, Jason Murray sold 232 shares of PACS Group stock. The shares were sold at an average price of $45.00, for a total value of $10,440.00.
- On Wednesday, October 7th, Jason Murray sold 717 shares of PACS Group stock. The stock was sold at an average price of $42.48, for a total value of $30,458.16.
- On Tuesday, October 6th, Jason Murray sold 35,975 shares of PACS Group stock. The shares were sold at an average price of $43.09, for a total transaction of $1,550,162.75.
- On Monday, October 5th, Jason Murray sold 24,224 shares of PACS Group stock. The shares were sold at an average price of $42.66, for a total transaction of $1,033,395.84.
PACS Group Price Performance
NYSE PACS opened at $49.08 on Thursday. The company has a quick ratio of 0.91, a current ratio of 0.91 and a debt-to-equity ratio of 0.21. The stock has a market capitalization of $7.77 billion, a PE ratio of 28.54, a price-to-earnings-growth ratio of 1.49 and a beta of -0.08. The company has a 50 day moving average price of $44.02 and a two-hundred day moving average price of $39.72. PACS Group, Inc. has a 12-month low of $10.31 and a 12-month high of $50.38.
PACS Group (NYSE:PACS – Get Free Report) last announced its quarterly earnings results on Tuesday, August 4th. The company reported $0.63 EPS for the quarter, topping the consensus estimate of $0.54 by $0.09. The company had revenue of $1.43 billion for the quarter, compared to analyst estimates of $1.41 billion. PACS Group had a net margin of 4.85% and a return on equity of 29.55%. As a group, equities analysts predict that PACS Group, Inc. will post 2.13 earnings per share for the current fiscal year.
Analyst Upgrades and Downgrades
PACS has been the topic of several recent research reports. Weiss Ratings upgraded PACS Group from a “hold (c)” rating to a “hold (c+)” rating in a report on Thursday, October 8th. Wall Street Zen downgraded PACS Group from a “strong-buy” rating to a “buy” rating in a research note on Saturday, August 8th. Truist Financial set a $62.00 price target on PACS Group in a research note on Wednesday, September 2nd. Zacks Research lowered PACS Group from a “strong-buy” rating to a “hold” rating in a report on Wednesday, September 9th. Finally, Oppenheimer increased their price target on PACS Group from $48.00 to $57.00 and gave the company an “outperform” rating in a report on Monday, August 10th. Five equities research analysts have rated the stock with a Buy rating and two have issued a Hold rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $58.80.
Get Our Latest Report on PACS Group
Institutional Inflows and Outflows
A number of institutional investors and hedge funds have recently bought and sold shares of the company. Nisa Investment Advisors LLC increased its stake in shares of PACS Group by 11.0% in the third quarter. Nisa Investment Advisors LLC now owns 2,327 shares of the company’s stock worth $97,000 after purchasing an additional 230 shares during the period. Financial Management Professionals Inc. increased its position in PACS Group by 54.9% in the 2nd quarter. Financial Management Professionals Inc. now owns 663 shares of the company’s stock worth $28,000 after buying an additional 235 shares during the period. Jacobsen Capital Management increased its position in PACS Group by 1.6% in the 1st quarter. Jacobsen Capital Management now owns 18,128 shares of the company’s stock worth $582,000 after buying an additional 294 shares during the period. Smith Group Asset Management LLC increased its position in PACS Group by 1.3% in the 3rd quarter. Smith Group Asset Management LLC now owns 24,680 shares of the company’s stock worth $1,025,000 after buying an additional 320 shares during the period. Finally, Toth Financial Advisory Corp boosted its position in shares of PACS Group by 87.5% in the third quarter. Toth Financial Advisory Corp now owns 1,500 shares of the company’s stock valued at $62,000 after acquiring an additional 700 shares during the period.
About PACS Group
PACS Group, Inc is a U.S.-based healthcare services company that owns and operates post-acute care facilities. Its platform focuses primarily on skilled nursing and transitional care, serving patients who require rehabilitation, recovery support, long-term care, and other services following hospitalization or acute medical treatment.
The company’s operations also include assisted living, independent living, and behavioral health services in select locations. Through its facilities and related healthcare capabilities, PACS Group provides services such as nursing care, physical and occupational therapy, speech therapy, medical treatment, and support for patients with complex or extended care needs.
Founded in 2013 and headquartered in Farmington, Utah, PACS Group serves communities across multiple U.S.
Featured Articles
- Five stocks we like better than PACS Group
- Boeing Got Its MAX 10 Approval, But Q3 Delivered a Reality Check
- The Invisible AI Backbone: Corning’s AI Fiber Play
- Heavy Metal: Why Nucor Could Be an Overlooked AI Infrastructure Winner
- Why Tesla’s Upside Is About More Than a SpaceX Merger
Receive News & Ratings for PACS Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PACS Group and related companies with MarketBeat.com's FREE daily email newsletter.
